间歇性与连续性静脉注射爱波醇用于治疗数字缺血症
Sarah Alsomairy1, Kristen T Pogue1,2, Karin M Durant1,2
1University of Michigan College of Pharmacy, Ann Arbor, MI, USA.
对数字性缺血的epoprostenol输注显示了连续和间歇方法之间的类似有效性和安全性. 持续输液导致住院时间缩短,这表明它可能是一个更有效的治疗选择.
科学领域:
- 血管医学 血管医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 数字性缺血,雷诺现象和全身性硬化症的痛苦并发症,涉及到四肢血管狭窄.
- 作为血管扩张剂的epoprostenol用于治疗受影响患者的数字缺血症.
研究的目的:
- 为了比较两种静脉注射epoprostenol用于数字缺血的施用技术的疗效和安全性.
- 为了评估持续和间歇输液方法之间的治疗失败率和不良反应.
主要方法:
- 72名患有数字缺血症的成年患者接受epoprostenol治疗的回顾性图表审查.
- 30小时连续输液与5天间歇性6小时输液的比较.
- 主要结局:治疗失败;次要结局:不良反应和停留时间.
主要成果:
- 连续 (33.3%) 和间歇 (20%) 输液组之间的治疗失败率没有统计学上显著的差异 (p=0.390).
- 在两组中,不良反应是相似的 (总体为28%).
- 接收连续输液的患者的平均停留时间显著缩短 (3天与8.9天相比,p<0.05).
结论:
- 连续与间歇性epoprostenol输注用于数字缺血的有效性和安全性概况并非完全可比.
- 连续30小时的输液提供较短的停留时间与5天间歇性协议相比.
- 治疗选择应根据患者的因素进行个性化,以优化数字缺血管理.
更多相关视频
11:49Autologous Endothelial Progenitor Cell-Seeding Technology and Biocompatibility Testing For Cardiovascular Devices in Large Animal Model
Published on: September 9, 2011
08:44Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema
Published on: September 1, 2016
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Pulse rhythm
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Clinical Applications of Epidermal Stem Cells
